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Summary A series of compounds in which a 2-nitroimidazole is linked to a DNA intercalating phenan-
thridine moiety has been synthesised. Previously, three such compounds, termed nitroimidazole-linked phenan-
thridines or NLPs, were tested in vitro and showed a greatly enhanced molar efficiency as hypoxic cell
radiosensitisers and cytotoxins compared with the untargeted 2-nitroimidazole, misonidazole. Since the cytoxi-
city of these compounds was shown to be inversely proportional to linker chain length while radiosensitising
ability was dependent of it, compounds with five and six carbons in the chain were synthesised in an attempt
to lower the toxicity of the drugs while increasing their ability to 'scan' DNA for target radicals. These
compounds and a comparison series of n-alkylated phenathridinium ions have been characterised and
evaluated in vitro using Chinese hamster ovary and V79 cells and their effects compared with misonidazole.
Based on in vitro results, one member of the series was selected and evaluated in vitro using a V79 spheroid
tumour model and in vivo using an SCCVII transplantable tumour system. These studies have demonstrated
the potential utility of this class of compound.
One approach taken in an attempt to improve the effective-
ness of 2-nitroimidazoles as hypoxic cell radiosensitisers and
cytotoxins is to localise the drugs around their presumed site
of action, DNA (Skov, 1989; Cowan et al., 1991; Denny et
al., 1992). In the present work, a DNA intercalating phenan-
thridine moiety has been attached to 2-nitroimidazoles by
hydrocarbon chains of varying lengths to produce the nitro-
imidazole-linked phenanthridine, or NLP, series of com-
pounds. In order to study the effects of the intercalating
moiety alone, a comparison series of N-alkylated phenan-
thridinium ions (the P series) without the nitroimidazole has
also been synthesised.
Previously, a report was published describing the physico-
chemical, radiosensitising and in vitro cytotoxic properties of
three members of the NLP series: NLP-1, -2 and -3 with
three, two and four carbons respectively in their linking
chains together with one member of the P series, P1, with
three carbons in the side chain (Cowan et al., 1991). In the
present paper, a more logical chemical nomenclature has
been adopted for the compounds in which the first number
gives the position of the nitro group on the imidazole ring
and the number of carbons in the linking chain is given after
the NLP designation. Under this system NLP-1, for example,
becomes 2-NLP-3 and P1 becomes P3. In the following
discussion, the old nomenclature is given in brackets follow-
ing the new names of the appropriate compounds.
The NLP series of compounds shows greatly enhanced
molar efficiency as hypoxic cell radiosensitisers and cytotox-
ins in vitro compared with the untargeted 2-nitroimidazole,
misonidazole (Miso), of the order of 10- to 100-fold based on
external drug concentrations (Cowan et al., 1991). Recently,
this series has been extended in an attempt to better under-
stand the mechanism of the observed increase in potency as
well as to try and improve efficacy further. Since cytotoxicity
of the NLP series has been previously shown to be inversely
proportional to the length of the linker chain over the range
of 2-4 carbons, while radiosensitising ability is independent
of it, compounds with five and six carbons in the chain have
been synthesised. These compounds, 2-NLP-5 and -6 respec-
tively, were designed to lower the toxicity of the drugs while
increasing their ability to 'scan' the DNA for target radicals.
The phenanthridinium ion series has also been extended to
include members spanning the range of 2-6 carbons. In the
present paper, we report on the properties of the new
members of the NLP and P series and compare the results
with previous compounds as well as with Miso in vitro. These
studies led to the selection of one compound, 2-NLP-3 (NLP-
1), for in vitro evaluation using the multicellular spheroid
tumour model and in vivo radiosensitisation studies, the
results of which are also presented.
Materials and methods
Cells
The cells used in most of the in vitro experiments were
Chinese hamster ovary cells (CHO) subline AA8-4 originally
obtained from Dr L.H. Thompson, Lawrence Livermore
Laboratory, Livermore, CA, USA, which were maintained in
tissue culture flasks in a-minimal essential medium (a-MEM)
supplemented with 10% fetal calf serum (FCS, Whitaker,
Walkersville, MD, USA) at 37°C in a humidified atmosphere
(95% air, 5% carbon dioxide). Asynchronous cultures for
experimental use were grown in glass spinner flasks in the
same growth medium at 37°C. Initially, samples of the
original culture were frozen and stored in liquid nitrogen.
New cultures were started from these samples every 3
months.
Since CHO cells do not readily form multicellular
spheroids, the Chinese hamster lung fibroblast line V79 was
employed in the spheroid studies. This line was obtained
from Dr I.F. Tannock of The Ontario Cancer Institute.
These cells grow well as monolayers and in suspension cul-
ture and were routinely maintained in plastic flasks under the
same conditions as the CHO cells. Experimental cultures
were started by trypsinising the flask and inoculating a spin-
ner flask with 5 x 106 cells in 200 ml. The cells were allowed
to form spheroids and grow for 3 days, after which time half
the medium was replaced. After 6 days growth the entire
medium was replaced and replaced again daily thereafter.
Spheroids were used in experiments when they reached a size
of 600-800ym as determined microscopically using a cali-
brated eyepiece.
For in vivo assays, the murine squamous cell carcinoma
line SCCVII/To originally isolated from a spontaneous
tumour of the abdomen of a C3H mouse by Dr H. Suit
(Harvard University, Boston, MA, USA) and adapted for in
vitro growth by Dr K Fu (University of California, San
Francisco, CA, USA) was used (Weinberg et al., 1986). It
was maintained by in vivo passage by implantation intramus-
cularly (i.m.) in the legs of syngeneic mice. For passage,
Correspondence: D.S.M. Cowan.
Received 25 March 1994; and in revised form 28 July 1994.
'." Macmillan Press Ltd., 1994 Br. J. Cancer (1994), 70, 1067-10741068 D.S.M. COWAN et al.
tumours were excised from the mice, minced with scissors,
digested to single-cell suspensions using a cocktail of 1,000
unitsml-l DNAse I (Sigma, St Louis, MO, USA) and 5%
trypsin (Difco, Detroit, ML, USA), and passed through a
fine mesh screen. Approximately 2 x 105 cells were then rein-
jected into 8- to 10-week-old mice.
Chemicals
All members of the NLP and P series of compounds were
synthesised and their structures confirmed in the same man-
ner as previously described for 2-NLP-3 (NLP-1) and P3 (P1)
(Panicucci et al., 1989). Misonidazole was a gift from The
National Cancer Institute (USA). All other chemicals, except
where noted, were purchased from Aldrich (Milwaukee, WI,
USA).
Physicochemicalproperties
Absorption spectra, used to determine the stability and con-
centration of the compounds, were determined on a Perkin
Elmer model L3B recording spectrophotometer coupled to a
personal computer. Partition coefficients were determined
using equal volumes of drug dissolved in phosphate-buffered
saline (PBS) and PBS-saturated 1-octanol at 24°C. High-
performance liquid chromatography (HPLC) was used to
confirm the stability of the compounds in growth medium at
37°C. A radial-Pak CN cartridge in a radial compression
cartridge holder (Millipore, Mississauga, Ontario, Canada)
was employed with a mobile phase of 99% methanol plus
1% 40 mmol dm-3 potassium bromide to provide an ion
pairing environment with a flow rate of 2 ml per min. Single
symmetrical peaks were observed with absorbance monitor-
ing at 254nm.
DNA binding
The DNA-binding properties of the compounds were deter-
mined using the ethidium bromide fluorescence displacement
method of Morgan et al. (1979) as described previously
(Cowan et al., 1991). The concentration of compound which
gave a 50% reduction in the fluorescence due to ethidium
bromide bound to calf thymus DNA was determined spectro-
fluorometrically with excitation at 525 nm and emission
measured at 600 nm. Binding constants were calculated using
the relationship that this concentration is inversely propor-
tional to the binding constant of the competing drug (Mor-
gan et al., 1979).
Chronic cytotoxicity
The cytotoxicity of the NLP and P series of compounds was
determined following 8 days of continuous exposure to
different concentrations of the drugs. Five hundred cells were
plated in each well of 24-well tissue culture dishes in 1 ml of
a-MEM plus 10% FCS. Cell numbers were determined using
an electronic particle counter. Volumes of 0.1 ml of different
drug concentrations were added to each well of the dishes
and the plates were incubated for 8 days in a humidified
atmosphere of 95% air plus 5% carbon dioxide at 37C. The
plates were then stained with 1% methylene blue in a 1:1
solution of95% ethanol and water. The highest drug concen-
tration which did not give cytotoxicity was determined by
visual inspection of the monolayers.
Acute cytotoxicity
Acute drug exposures were carried out in stirred suspensions
of CHO or V79 cells at 1 x 106 cells ml' in glass polyshell
vials at 37°C. The cells were gassed with either 95% air plus
5% carbon dioxide for aerobic exposures or 95% nitrogen
plus 5% carbon dioxide to produce hypoxia. Cell suspensions
were allowed to equilibrate with the gas mixtures for 45 min
prior to drug addition. Following equilibration, drug was
added at a concentration of 0.5 mmol dm-3. For hypoxic
exposure conditions, the drug solution was prebubbled with
95% nitrogen plus 5% carbon dioxide. To determine sur-
vival, 0.1 ml aliquots of cells were removed as a function of
time, diluted and plated to give l12_ 105 cells on 60 mm tissue
culture dishes. The plates were incubated for 8 days, stained
with methylene blue and examined for colony-forming
ability. Colonies of 50 or more cells were counted. Plating
efficiency was determined and plotted vs time of drug
exposure on semilogarithmic graphs.
Spheroidcytotoxicity studies
The ability of the compounds to penetrate through several
cell layers was assayed for using the multicellular spheroid in
vitro tumour model and the lead compound in the series,
2-NLP-3 (NLP-1). V79 Chinese hamster lung fibroblast cells
were allowed to form spheroids in suspension culture until
they reached a diameter of 600-800 ,um. Spheroids were
transferred to polyshell vials with magnetic stirrers and
gassed with 95% air plus 5% carbon dioxide as described
above, and exposed to either 0.5 mmol dm-3 2-NLP-3 (NLP-
1) dissolved in PBS or PBS alone. Samples of the spheroids
were removed from the stirred suspension cultures as a func-
tion of time of drug exposure and made into single-cell
suspensions using a combination of 0.5% trypsin and gentle
mechanical agitation. Cell survival over the period of 0-5 h
was determined as described above. The cytotoxicity of 2-
NLP-3 (NLP-1) was also tested against V79 cells exposed as
single-cell suspensions. V79 spheroids were disaggregated as
described above and resuspended to a final concentration of
1 x 106 cells ml-' immediately prior to drug treatment under
aerobic or hypoxic exposure conditions.
In vitro radiosensitisation
The radiosensitising ability of the NLP and P series of com-
pounds was determined in a similar manner as acute cyto-
toxicity experiments except that samples were removed as a
function of radiation dose. Drug was added immediately
prior to irradiation with 'Co gamma rays delivered at a dose
rate of 1.4-1.6 Gymin'1. Total irradiation times were
typically less than 30 min. Absolute plating efficiencies were
determined and plotted as a function of radiation dose on
semilogarithmic graphs.
In vivo toxicity
The tolerable dose of 2-NLP-3 (NLP-1) was determined by
intraperitoneal (i.p.) injection of the drug dissolved in sterile
PBS into male C3H mice. The initial concentration used was
0.02 mg gm- mouse body weight, and this level was in-
creased sequentially. The mice were examined for signs of
toxicity, such as weight loss, at each dose level over a period
of at least 60 days.
In vivo radiosensitisation
The radiosensitising ability of 2-NLP-3 (NLP-1) in vivo was
determined using the SCCVII/To tumour in a regrowth delay
assay. SCCVII/To cells were implanted i.m. into the left hind
leg of C3H mice and the tumours allowed to grow to a size
of 0.3-0.4 g. When the tumours reached the appropriate size,
the animals were given i.p. injections of 2-NLP-3 (NLP-1),
Miso or PBS 45 min prior to the commencement of irradia-
tion. Local irradiation using 100 kVp X-rays from a double-
headed X-ray machine was given to unanaesthesized mice
restrained in lucite jigs as described previously (Siemann et
al., 1977). The jig was placed in a lucite irradiation chamber
containing upper and lower lead collimators 22 mm in
diameter with the tumours centred in the radiation field.
Tumour size was measured every other day following irradia-
tion by passing the mouse legs through calibrated rods. The
mice were culled when their tumours reached a size of 2.33 g
or if they were in obvious distress. Tumour weight in grams,
as determined from a calibration curve of diameter to weightCHAIN LENGTH EFFECTS ON DNA-TARGETED COMPOUNDS 1069
(Weinberg et al., 1986), was plotted as a function of time for
the tumour of the median mouse in each treatment group to
regrow to a size of 2.33 g.
Results
Physicochemical properties
Structures for the NLP and P series of compounds are given
in Figure 1. Purity of the compounds, in excess of 99%, was
confirmed by high-field nuclear magnetic resonance (NMR)
and HPLC analysis. All of the NLP or P compounds gave
similar characteristic UV/visible absorption spectra which
indicated that the compounds were stable when dissolved in
PBS and stored at either 4°C or room temperature for at
least 1 week. HPLC analysis confirms the compounds are
also stable in growth medium at 37°C for a similar length of
time. The partition coefficients of the compounds are given in
Tables I and II for the NLP and P series respectively. The
value of the partition coefficient is at a maximum with the
compound which has the shortest chain linking the nitro-
imidazole to the phenanthridine, two carbons, 2-NLP-2
(NLP-2), decreases to a minimum with the four-carbon linker
compound, 2-NLP-4 (NLP-3), and then begins to rise again
as the chain length is increased further to five and six car-
bons (Table I). This is contrary to partition coefficient




















Figure 1 a, Structure of the NLP series of compounds. b, Struc-
ture of the P series of compounds.
Table I Binding constants, partition coefficients, and chronic
cytotoxicity data for the NLP series of compounds
Binding Chronic
Partition constant cytotoxicity
Compound coefficient (JO¶ x mol-') (mmoldm3')
2-NLP-2* 2.72 + 0.01 1.12 ± 0.06 0.06 ± 0.02
(NLP-2)
2-NLP-3* 0.53 ± 0.01 3.51 ± 0.35 0.12 ± 0.01
(NLP-1)
2-NLP-4* 0.31 0.01 6.4 2.0 0.15 0.02
(NLP-3)
2-NLP-5 0.52 ± 0.01 4.7 ± 1.3 0.06 ± 0.01
2-NLP-6 1.03 ± 0.01 11.3 + 3.2 0.03 + 0.01
*From Cowan et al. (1991).
chain should increase the lipophilicity of the drugs (Brown &
Workman, 1980). In contrast, the partition coefficients of the
P series show the expected results, with the partition
coefficient value being the lowest for the shortest chain com-
pound, P2, and increasing to a maximum for the drug with
the longest side chain, P6 (Table II).
DNA binding
DNA-binding values, as calculated by the ethidum bromide
displacement assay, are given in Table I and II. In the case of
the NLP series of compounds, the level of DNA binding
correlates, with one exception, with the length of the linking
chain - the longer the chain, the higher the amount of
binding observed (Table I). This pattern is probably due to
steric effects at the shorter chain lengths involving the nitro-
imidazole preventing the phenanthridine group from effec-
tively interacting with the DNA. The reason why 2-NLP-5
does not follow this pattern is not clear. The members of the
P series of compounds all display similar DNA binding
affinities in the range of approximately 1-2.5 x 10imol'
(Table II).
Chronic cytotoxicity
The results of experiments involving 8 days' continuous
exposure to the NLP and P drugs are shown in Tables I and
II. The NLP series of compounds decrease in their cytotoxi-
city under continuous exposure conditions with each addi-
tional carbon in the linking chain over the range of 2-4
carbons. The cytotoxicity then increases again as the chain is
lengthened to five and six carbons. The P series of com-
pounds display a direct correlation between chain length and
cytotoxicity. The compound with the shortest chain length is
the least toxic and cytotoxicity increases with each additional
carbon in the chain to a maximum with P6.
Acute cytotoxicity
The cytotoxic effects of the NLP and P series over a 5 h
exposure to an 0.5 mmol dm-3 concentration, under both
hypoxic and aerobic conditions, were investigated and the
results are presented in Figure 2 for 2-NLP-5 and 2-NLP-6,
Figure 3 for P5 and P6 and Tables III and IV for all of the
compounds. For the NLP series of compounds, cytotoxicity
towards both hypoxic and aerobic cells decreased with in-
creasing linker chain length over the range of 2-4 carbons
(Table III). This relationship continued with five carbon
chain compound, 2-NLP-5, but hypoxic cytotoxicity began to
increase again with the addition of another carbon to the
chain (Table III; Figure 2). The hypoxic/aerobic cytotoxicity
differential was at least four for all the NLPs, when this
could be determined, and possibly much higher for the less
toxic analogues. The acute cytotoxicity of the NLP com-
pounds did not correlate closely with their partition
coefficients. This series of drugs is approximately 40-fold
more cytotoxic to aerobic cells on a molar basis than is the
untargeted 2-nitroimidazole, Miso (Cowan et al., 1991;
Panicucci et al., 1989). Untreated control cultures showed no
decrease in survival over 5 h under either hypoxic or aerobic
exposure conditions (Figures 2 and 3).
The P series of compounds exhibited no cytotoxicity to
Table II Binding constants, partition coefficients, and chronic
cytotoxicity data for the P series of compounds
Binding Chronic
Partition constant cytotoxicity
Compound coefficient (JOs x mol') (mmoldm-3)
P2 0.31 ± 0.01 2.61 + 0.26 0.16± 0.03
P3 0.52 0.01 1.90 0.34 0.13 ± 0.02
P4 1.03±0.01 1.13±0.22 0.11 ±0.04
P5 3.31 0.01 1.77 0.16 0.08 ± 0.02
P6 12.10 0.01 2.07 0.23 0.05 ± 0.011070 D.S.M. COWAN et al.
either hypoxic or aerobic conditions over a 5 h exposure for
compounds with side chains of 2-4 hydrocarbons (Table
IV). Significant cytotoxicity was observed with P5, with five
carbons in the side chain, and this increased further when an
additional carbon was added to produce P6 (Figure 3). The
cytotoxicity of P5 and P6 was equivalent towards hypoxic
and aerobic cells. The cytotoxicity of the P series correlates








Figure 2 Acute cytotoxicity of 0.5 mmol dm-3 2-NLP-5 (0,0)
and 2-NLP-6 (O,) towards stirred suspensions of CHO cells
under aerobic (open symbols) and hypoxic (closed symbols)
exposure conditions. Triangles represent untreated cells under
aerobic (open) and hypoxic (closed) exposure conditions. Points
represent the means of at least three experiments and represen-
tative error bars are the standard deviations of those means.
Table III Toxicity and radiosensitising properties of the NLP series
of compounds at 0.5 mmol dm-3 in the extracellular medium
Time to 10% Time to 10%
aerobic hypoxic SER at 10%
Compound survival (h) survival (h) survival
2-NLP-2* 4.8 0.8 2.7
(NLP-2)
2-NLP-3* 5.0 1.1 2.7
(NLP-1)
2-NLP-4* 8.6 1.8 2.7
(NLP-3)
2-NLP-5 >5 4.5 2.1
2-NLP-6 >5 1.6 1.9
*From Cowan et al. (1991).
Table IV Toxicity and radiosensitising properties of the P series of
compounds at 0.5 mmol dm-3 in the extracellular medium
Time to 10% Time to 10%
aerobic hypoxic SER at 10%
Compound survival (h) survival (h) survival
P2 >5 >5 1.0
P3 >5 >5 1.0
P4 >5 >5 1.0
P5 3.5 3.5 1.0
P6 1.5 1.5 1.0
Spheroid cytotoxicity studies
The ability of the compounds to penetrate through multiple
cell layers was demonstrated in the spheroid in vitro tumour
model. The cytotoxicity of 2-NLP-3 (NLP-1) was tested for
with intact V79 spheroids and compared with that seen for
spheroids disassociated to single-cell suspensions and
immediately exposed to drug (Figure 4). A drug concentra-
tion of 0.5 mmol dm-3 produced cytotoxicity towards both
aerobic and hypoxic single-cell suspensions of V79 cells re-
sulting in approximately one log of cell kill under aerobic
conditions over 5 h. This cytotoxicity was greatly enhanced
under hypoxic conditions, of the order of 10-fold. Significant
cytotoxicity was also observed when stirred suspensions of
intact spheroids of 600ltm diameter were exposed to
0.5 mmol dm-3 2-NLP-3 (NLP-1) under aerobic exposure
conditions. The observed cytotoxicity was intermediate
between that seen for the hypoxic and aerobic exposures of
the single V79 cells producing approximately four decades of
cell kill over the period of 0-3 h (Figure 4). This result
indicates that the DNA targeted compound can diffuse
through at least several cell layers.
Radiosensitisation in vitro
The in vitro radiosensitising ability of the NLP and P series
was investigated using stirred suspensions of CHO cells
exposed to an 0.5 mmol dm-3 concentration of drug under
hypoxic and aerobic conditions. Sensitiser enhancement
ratios (SERs) were calculated at the 10% survival level using
a clonogenic assay. Essentially identical enhancement ratios
were obtained with 2-NLP-2 (NLP-2) to 2-NLP-4 (NLP-3)
with 2-4 carbons in the linking chain (Table III; Cowan et
al., 1991). Sensitising ability diminished when the chain was
increased to five carbons (Figure 5a). This diminution was
increased slightly further when the chain was extended to six
carbons (Figure Sb) but not to a statistically significant
degree. A small but reproducible protection of aerobic cells
was seen with each of the NLP compounds with linking
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Figure 3 Acute toxicity of P5 (0,0) and P6 (OH,) towards
stirred suspensions of CHO cells under aerobic (open symbols)
and hypoxic (closed symbols) exposure conditions. Triangles
represent untreated cells under aerobic (open) and hypoxic
(closed) exposure conditions. Points represent the means of at
least three experiments and representative error bars are the











Figure 4 Toxicity of 0.5 mmol dm-3 2-NLP-3 (NLP-1) towards
intact (0) and dissociated V79 spheroids (O,) under aerobic
(open symbols) and hypoxic (closed symbols) exposure condi-
tions. Control cells showed no loss in survival under aerobic or
hypoxic conditions over the period of 0-5 h. Points represent the
mean of at least three experiments and representative error bars
are the standard deviations of those means.
al., 1991). This protection decreased with the SER when the
exposue concentration was lowered. The NLP compounds
are up to 10-100 times more efficient on a molar basis as
hypoxic cell radiosensitisers than the untargeted 2-
nitroimidazole, Miso (Brown, 1984). None of the P series of
compounds altered the radiation response of either hypoxic
or aerobic cells (Table IV).
In vivo toxicity
Based on the in vitro results obtained with the NLP and P
series of compounds, the lead compound 2-NLP-3 (NLP-1)
was chosen for in vivo testing. Following i.p. injection of
2-NLP-3 (NLP-1) into C3H mice, the animals appeared
lethargic and sensitive to light at all doses studied for a
period of up to 2 h. Using standard toxicity determinants
such as weight loss, however, no chronic toxicity was
observed at any non-lethal concentration of the drug used.
At higher concentrations, death from drug administration
occurred rapidly, usually within 5-0 min following injec-
tion, and was characterized by violent convulsions. If the
animals survived beyond 1 h post injection, drug-mediated
death did not occur during a follow-up period of at least
60 days. Autopsies of mice given lethal doses of 2-NLP-3
(NLP-1) revealed no readily discernible cause of death. The
maximally tolerated dose of 2-NLP-3 (NLP-1) was approxi-
mately one-tenth that of Miso (Rauth et al., 1980).
In vivo radiosensitisation
The in vivo radiosensitising ability of 2-NLP-3 (NLP-1) was
tested using the SCCVII tumour in a regrowth delay assay.
SCCVII/To tumours growing in the left hind leg were treated
with local irradiation when leg diameters reached a size of
9-1O mm. Either 2-NLP-3 (NLP-1), Miso or PBS was ad-
ministered i.p. 45 min prior to treatment with a single dose of
20 Gy. 2-NLP-3 (NLP-1) was given at dose levels of approxi-
mately 25%, 12.5% and 6.25% of the estimated LD50, corre-








Figure 5 Radiosensitising ability of 0.5 mmol dm-3 2-NLP-5 (a),
and 2-NLP-6 (b) towards stirred suspensions of CHO cells under
aerobic (L) and hypoxic (U) exposure conditions. Open symbols
represent non-drug treated cells under aerobic (0) and hypoxic
(0) conditions respectively. Points represent the means of at least
three experiments and representative error bars are the standard
deviations of those means.
(0.085, 0.042 and 0.022 mmol kg-' respectively) of mouse
body weight. Miso was given at a concentration of
0.15 mg m'l (0.75 mmol kg-') which corresponds to about
10% of the LD50 of this compound (Rauth et al., 1980). Both
Miso and 2-NLP-3 (NLP-1) produced significant growth
delays over radiation alone at all concentrations used (see
Figure 6 for representative data). The two highest levels of
2-NLP-3 used, 0.035 and 0.0175 mg g-', resulted in identical
levels of sensitisation, with a mean time to regrow to 2.33 g
of 48 ± 5 days, which were approximately equivalent to the
delay seen when 0.15 mg g ' Miso was used in these
experiments (mean regrowth time of 36 ± 7 days). The lowest
dose of 2-NLP-3 (NLP-1) administered resulted in a more
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Figure 6 Representative regrowth delay results using the
SCCVII tumour treated with 20 Gy irradiation plus: 0.009 (A);
0.0175 (V); 0.035 (*) mgg- 2-NLP-3 (NLP-1) or 0.15mgg'
Miso (+). Squares represent treatment with PBS in the absence
of radiation and circles represent treatment with radiation alone.
modest, but still significant, delay over radiation alone (mean
regrowth time of 36 ± 4 days). Radiation alone produced a
mean regrowth time of 24 ± 3 days. Errors quoted are the
standard errors of the mean for n = 7. All of the drug-
treated groups produced regrowth delays which were statis-
tically different from radiation alone with P-values of 0.007,
0.0478 and 0.022 for the high and low doses of 2-NLP-3
(NLP-1) and Miso respectively using the Mann-Whitney
test.
Discussion
The NLP series of compounds shows a significant increase in
potency over untargeted 2-nitroimidazoles as in vitro hypoxic
cell cytotoxins and radiosensitisers based on external drug
concentrations. The acute cytotoxic potency of the com-
pounds decreases as the length of the chain linking the
nitroimidazole to the intercalating phenanthridine moiety is
increased over the range of 2-5 carbons. A reasonable hypo-
thesis for the inverse relationship between chain length and
toxicity is that at longer chain lengths the nitroimidazole is
further from its target, DNA, resulting in reduced cytotoxic
efficacy. Cytotoxicity appears to begin to increase again as
the chain is lengthened further to six carbons. A similar
situation is seen under chronic exposure conditions with
cytotoxicity decreasing as the chain length is increased over
the range of 2-4 carbons followed by a rise in cytotoxicity as
the chain length is increased further.
One possible explanation for this increase is more effective
partitioning into the cells as the number of carbons in the
compounds is raised (Brown & Workman, 1980). The results
obtained do not support this hypothesis, however, as the
chain lengths of the NLP compounds do not correlate with
their partition coefficients. The reason for the departure from
partition coefficient theory by the NLP compounds is
pseudobase formation by the drugs (Bunting, 1979). In solu-
tion there is a transient attraction of hydroxyls to the carbon
adjacent to the nitrogen in the phenanthridine ring system.
This so-called pseudobase, which can be measured spectro-
photometrically, acts to neutralise the positive charge on the
compounds, thereby increasing their lipophilicity. The shorter
chain compounds are more effective at forming pseudobases
(data not shown), which explains the relatively high partition
coefficient seen with 2-NLP-2.
One potential problem with the use of DNA-targeted com-
pounds is their propensity to form large intracellular to
extracellular drug ratios mediated by concentration gradients
formed as the compounds cross both the cellular and nuclear
membranes. This phenomenon has been seen with DNA
intercalating nitroacridines, which have DNA-binding con-
stants 5-50 times that of 2-NLP-3 (Roberts et al., 1990).
These compounds showed a very high molar efficiency, in the
low micromolar range, as hypoxic cell cytotoxins, but at least
part of this effect was caused by high intracellular concentra-
tions of the compounds, on the order of 25-300 times the
external concentration. The cytotoxicity of 2-NLP-3 (NLP-1)
cannot be simply explained by a large intracellular accumula-
tion of the drug. Using a radioactive uptake assay, similar
accumulation patterns for 2-NLP-3 (NLP-1) and Miso were
observed under both hypoxic and aerobic conditions, sug-
gesting that the phenanthridine targeting group on 2-NLP-3
(NLP-1) does not result in intracellular accumulation (Cowan
et al., 1992), and it is reasonable to conclude that this is also
true for the rest of the NLP series. However, owing to the
low specific activity of the drug used in these experiments, it
was necessary to use a relatively high concentration of the
compound and it is possible that small levels ofaccumulation
might not be detected (Cowan et al., 1992). These results are
currently being confirmed for 2-NLP-3 (NLP-1) and the rest
of the NLP compounds using an HPLC technique.
In contrast to the NLP series, the cytotoxicity of the
comparison P series of N-alkylated phenanthridinium ions
does correlate directly with both side chain length and parti-
tion coefficient under either chronic or acute exposure condi-
tions. There is no differential cytotoxicity seen with the P
compounds. The fact that no cytotoxicity is observed with P3
(P1) suggests, surprisingly, that the aerobic cytotoxicity seen
with 2-NLP-2 through 2-NLP-4 is mediated through the
nitroimidazole rather than the intercalating phenanthridine
moiety. This cytotoxicity is possibly via the futile cycling of
the nitro group with the concomitant production of reactive
oxygen species.
The present results with P3 (P1) do not agree with our
previous studies in which significant cytotoxicity was
observed at a drug concentration of 0.5 mmol dm 3. This
cytotoxicity was equal towards both hypoxic and aerobic
cells and, based on these results, the aerobic cytotoxicity of
the NLP compounds was attributed to the intercalation of
the targeting moiety into DNA (Cowan et al., 1991). The
lack of cytotoxicity observed with P3 (P1) in the present
studies suggests a low level of contamination in the original
preparation of P1, with the likely candidate being phenan-
thridine, the starting material in the synthesis. Controls per-
formed with the original and subsequent batches of the
NLPs, in which essentially identical cytotoxicity and sen-
sitisation results were observed between the batches (data not
shown), suggests that this contamination was not a confoun-
ding factor in results reported previously for the NLP com-
pounds.
All of the NLP compounds are potent radiosensitisers of
hypoxic cells in vitro based on external drug concentrations.
Over the range of 2-4 carbons in the linking chain, almost
the full oxygen effect can be achieved at an extracellular drug
concentration of 0.5mmoldm-3 (Table III; Cowan et al.,
1991). As the chain length is increased further, a slight
reduction in sensitising efficiency is observed (Figure 4).
Therefore, rather than allowing the compounds to more
efficiently 'scan' the DNA for target radicals as proposed, the
longer chains appear to act by simply holding the nitro-
imidazole away from its target, resulting in a lower level of
sensitisation. All the NLP drugs with linking chains of fewer
than five carbons produce a small but reproducible radio-
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explanation for this is that the nitroimidazole protruding
from the DNA helix acts as a trap for the reactive water
species produced by the radiation preventing them from
reaching the DNA and causing damage. Another possible
protection mechanism is that the NLP compounds may slow
progression through the cell cycle allowing for an increase in
the time available for the cells to repair radiation-induced
damage, as has been previously postulated for the DNA-
binding radioprotector, Hoechst 33342 (Smith & Anderson,
1984). Lowering the external drug concentration used in
these experiments resulted in reductions in the level of both
hypoxic cell sensitisation and protection of aerobic cells (data
not shown). Depending on the drug concentration used, the
NLP compounds are 10-100 times more effective as hypoxic
cell sensitisers than the untargeted 2-nitroimidazole Miso
based on external drug concentrations. None of the P series
altered the radiation response of hypoxic or aerobic cells
(Table IV), demonstrating that the NLPs act by an electron
affinic radiosensitisation mechanism.
As shown previously for 2-NLP-3 (NLP-1) (Cowan et al.,
1991), the SER vs drug concentration curve is steeper for the
NLP compounds than it is for Miso. This is in contrast to
what has been seen previously for a 2-nitroimidazole linked
to a quaternary base (a morpholine group) by a four-hydro-
carbon chain where a shallower SER vs drug concentration
curve was seen compared to Miso (Adams et al., 1980a). This
difference likely reflects the effect of targeting the 2-nitro-
imidazole to DNA via the intercalating phenanthridine of the
NLP compounds.
Previous work by Adams et al. (1980b) has studied the
dependency of the sensitising efficiency of 2-nitroimidazoles
on the length of the hydrocarbon chain, linking them to
positively charged, non-intercalating morpholine groups.
Radiosensitising efficiency increased as the chain was length-
ened, reaching a maximum at 4-5 carbons, and then de-
creased for linking chains up to 11 carbons in length. The
chronic cytotoxicity of the morpholine group increased
monotonically with chain length. The present results for the
NLP compounds differ from these results in that radiosen-
sitising efficiency was constant over 2-4 carbons and then
decreased as the chain was lengthened to five and six car-
bons, while chronic cytotoxicity was at a minimum at four
carbons. Clearly, linking a DNA targeting group to a 2-
nitroimidazole via hydrocarbon chains of varying lengths
produces results different from those seen with the attach-
ment of a non-intercalating group. The causes of these
differences remains to be determined.
Evidence of the ability of the NLP compounds to pass
through several cell layers has been obtained in vitro using
the multicellular spheroid tumour model. Studies with intact
vs disassociated spheroids demonstrated significant cytotoxi-
city in both systems, with the spheroid cytotoxicity being
intermediate between that seen for the single cells under
aerobic compared with hypoxic exposure conditions (Figure
4). Assuming a diffusion distance for oxygen of 150jLm
(Thomlinson & Gray, 1955; Tannock, 1972) and a V79 cell
size of 10-15pgm, the compound would have to diffuse
through 10-15 cell diameters to reach the hypoxic cells.
Since the cytotoxicity observed in the intact spheroid case is
greater than can be explained through aerobic killing alone,
penetration of 2-NLP-3 (NLP-1) through multiple cell layers
does not appear to be a major limitation in this class of
compounds. Further preliminary evidence to support this
result comes from a fluorescence-activated cell sorting tech-
nique in which spheroids are stained with the DNA dye
Hoescht 33342, exposed to the drug, disassociated and sorted
as a function of fluorescence intensity into four fractions.
The cells are then plated and assayed for clonogenic survival.
A similar pattern of cytotoxicity was seen in this system with
the dimmest and therefore presumably most hypoxic fraction
demonstrating significant cytotoxicity, again suggesting that
2-NLP-3 (NLP-1) could penetrate to this region (D.S.M.
Cowan, unpublished results).
The in vivo toxicity of 2-NLP-3 (NLP-1) is approximately
10-fold greater than that seen for Miso. The acute toxic
effects seen after administration of either 2-NLP-3 (NLP-1)
or Miso were similar and appeared to include neurological
involvement. Animals surving 1-2 h post administration
suffered no deleterious complications, as has been seen
previously for Miso (Rauth et al., 1980).
Regrowth delay assays demonstrated significant activity in
the SCCVII/To tumour (Figure 6), indicating that the NLP
compounds are capable ofpenetrating through the tumour to
reach the hypoxic cells and overcoming one of the limitations
suggested for the use of other DNA targeted compounds in
vivo (Roberts et al., 1990; Denny et al., 1992). Sensitisation
of hypoxic cells equal to that seen with Miso was achieved at
2-NLP-3 (NLP-1) concentrations approximately 20-fold
lower than Miso on a molar basis. Lowering the concentra-
tion further, to about 1/40th that of Miso, still produced
sensitisation of hypoxic cells albeit to a more modest extent.
However, since 2-NLP-3 (NLP-1) is approximately 10-fold
more toxic than Miso, it may be no better than Miso in
sensitising tumours when therapeutic ratios are compared. A
complete dose-response comparison between Miso and 2-
NLP-3 (NLP-1) is an important extension of this work and
those studies are currently under way. Post-irradiation injec-
tion of 2-NLP-3 (NLP-1) produced no significant delay in
tumour regrowth over that seen with radiation alone (data
not shown). In addition, no anti-tumour effect was observed
when the compound was administered in the absence of
radiation (data not shown). These results suggest that at least
the majority of the effect observed in vivo is due to radiosen-
sitisation by the DNA-targeted compound.
The present studies suggest that targeting electron affinic
compounds to DNA is an effective way of increasing their
hypoxic cell cytotoxicity and radiosensitising potency in vitro
and indicates the potential utility of this approach in vivo.
Whether it is possible to further reduce the normal tissue
cytotoxicity of such compounds, increase their sensitising
potency in vivo or both enough to make them potential
candidates for clinical evaluation remains unclear. Possible
modifications to the compounds include alterations at both
the electron affinic end as well as the targeting end and both
these possibilities are being investigated.
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